Back to top
more

Merit Medical Systems (MMSI)

(Delayed Data from NSDQ)

$88.74 USD

88.74
1,093,175

+4.62 (5.49%)

Updated Aug 2, 2024 04:00 PM ET

After-Market: $88.71 -0.03 (-0.03%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.03%
2Buy17.70%
3Hold9.37%
4Sell5.03%
5Strong Sell2.48%
S&P50011.19%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value C Growth C Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 15% (214 out of 251)

Industry: Medical - Dental Supplies

Better trading starts here.

Zacks News

Here's Why You Should Hold Becton, Dickinson Stock for Now

Becton, Dickinson's (BDX) MAX enteric viral panel receives FDA clearance.

DENTSPLY's (XRAY) Preliminary Q4 Results Cheer Investors

DENTSPLY (XRAY) expects to see solid performance in Europe and the rest of the world.

Here's Why You Should Buy Varian Medical (VAR) Stock Now

Buoyed by a strong first quarter, Varian Medical (VAR) has kept its fiscal 2019 guidance intact.

Merit Medical (MMSI) Q4 Earnings & Revenues Surpass Estimates

Merit Medical (MMSI) registers solid expansion in adjusted gross margins in fourth-quarter 2018.

Zacks.com featured highlights include: Merit Medical, Pinnacle West, Amedysis, Southwest Airlines and Royal Caribbean

Zacks.com featured highlights include: Merit Medical, Pinnacle West, Amedysis, Southwest Airlines and Royal Caribbean

Worried About Rate Hikes? Buy These 5 Low Leverage Stocks

If a company is highly leveraged, investors will not add it to their portfolios. A high degree of financial leverage means high interest payments, which may affect a company's bottom line.

Zacks.com featured highlights include: Merit Medical, Pinnacle West, Steelcase, Southwest and EMCOR

Zacks.com featured highlights include: Merit Medical, Pinnacle West, Steelcase, Southwest and EMCOR

Bet on These 5 Low Leverage Stocks to Escape Debt Traps

With the Q4 earnings season in full swing currently, investors must be targeting companies with solid earnings growth projections. But they must consider their debt level first.

3 Reasons Growth Investors Will Love Merit Medical (MMSI)

Merit Medical (MMSI) is well positioned to outperform the market, as it exhibits above-average growth in financials.

Top Ranked Growth Stocks to Buy for January 15th

Here are four stocks with buy ranks and strong growth characteristics for investors to consider today, January 15th

The Zacks Analyst Blog Highlights: Anthem, Ensign, NeoGenomics, Merit Medical Systems and Medpace

The Zacks Analyst Blog Highlights: Anthem, Ensign, NeoGenomics, Merit Medical Systems and Medpace

5 Healthcare Bets to Stay in Investors Good Books Next Year

Based on a few key factors, we zero in on five stocks that show promise to retain the bull run in 2019.

Here's Why You Should Invest in Merit Medical (MMSI) Now

A strong outlook for 2018 and a solid global foothold make Merit Medical (MMSI) a promising investment pick.

Should You Invest in the Invesco S&P SmallCap Health Care ETF (PSCH)?

Sector ETF report for PSCH

Merit Medical (MMSI) Completes Cianna Medical Acquisition

Merit Medical (MMSI) is likely to gain traction in the global breast lesion localization market, courtesy of the Cianna Medical acquisition.

GNC Holdings (GNC) Q3 Earnings Miss on Soft U.S. Retail

GNC Holdings (GNC) discourages with sluggish domestic retail comps. However, it delivers a strong performance in e-commerce business as well as at International segment.

Phibro Animal (PAHC) Q1 Earnings Lag Estimates, Sales Up Y/Y

Within Animal Health business of Phirbo Animal (PAHC), reduced selling prices across certain countries partially offset its international volume growth.

OPKO Health (OPK) Incurs Loss in Q3, Lags Revenue Estimates

OPKO Health (OPK) gains from robust demand for its flagship RAYALDEE in Q3; adjusted gross margin remains pressed.

Haemonetics (HAE) Earnings & Revenues Beat Estimates in Q2

Haemonetics' (HAE) year-over-year growth in Q2 is backed by benefits from complexity reduction and investments along with strength in market demand and success from early launches.

athenahealth (ATHN) Q3 Earnings Beat, Bookings Down Y/Y

athenahealth's (ATHN) Business and Services unit sees a strong Q3; 2018 guidance maintained.

DexCom (DXCM) Beats Q3 Earnings Estimates, Raises '18 View

Solid contribution from the Sensor, Transmitter and Receiver segments drives DexCom's (DXCM) Q3 results.

Can Canadian Market Drive Canopy Growth (CGC) Q2 Earnings?

Canopy Growth (CGC) is poised to gain from continued strength in the Canadian medical cannabis market in the fiscal second quarter.

DENTSPLY SIRONA (XRAY) Q3 Earnings & Revenues Miss Estimates

DENTSPLY SIRONA (XRAY) witnesses dismal segmental performance in Q3; 2018 guidance lowered.